Daiwa Securities Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.8M Buy
87,742
+5,971
+7% +$1.24M 0.04% 247
2026
Q1
$17.3M Buy
81,771
+4,624
+6% +$996K 0.05% 218
2025
Q4
$15.9M Sell
77,147
-4,212
-5% -$793K 0.05% 218
2025
Q3
$12.8M Buy
81,359
+1,225
+2% +$189K 0.04% 246
2025
Q2
$13.5M Buy
80,134
+3,992
+5% +$592K 0.05% 218
2025
Q1
$10.5M Buy
76,142
+16,473
+28% +$2.1M 0.04% 234
2024
Q4
$7.06M Buy
59,669
+8,066
+16% +$942K 0.03% 316
2024
Q3
$5.7M Buy
51,603
+15,195
+42% +$1.59M 0.03% 349
2024
Q2
$3.58M Sell
36,408
-1,345
-4% -$137K 0.02% 418
2024
Q1
$4.22M Buy
37,753
+10,317
+38% +$1.11M 0.02% 367
2023
Q4
$2.77M Buy
27,436
+178
+0.7% +$17.7K 0.02% 440
2023
Q3
$2.37M Buy
27,258
+1,015
+4% +$91.8K 0.02% 458
2023
Q2
$2.48M Buy
26,243
+2,262
+9% +$191K 0.02% 436
2023
Q1
$1.81M Buy
23,981
+834
+4% +$62.9K 0.01% 520
2022
Q4
$1.78M Sell
23,147
-1,224
-5% -$93K 0.01% 501
2022
Q3
$1.63M Buy
24,371
+712
+3% +$45.1K 0.01% 503
2022
Q2
$1.24M Buy
23,659
+6,258
+36% +$356K 0.01% 585
2022
Q1
$987K Buy
17,401
+464
+3% +$24.9K 0.01% 707
2021
Q4
$872K Buy
16,937
+945
+6% +$46.3K 0.01% 747
2021
Q3
$791K Buy
15,992
+316
+2% +$17.1K 0.01% 736
2021
Q2
$895K Buy
15,676
+833
+6% +$48.7K 0.01% 689
2021
Q1
$902K Buy
14,843
+580
+4% +$32K 0.01% 654
2020
Q4
$764K Buy
14,263
+329
+2% +$17.1K 0.01% 648
2020
Q3
$654K Buy
13,934
+755
+6% +$38.7K 0.01% 617
2020
Q2
$632K Hold
13,179
0.01% 473
2020
Q1
$632K Hold
13,179
0.01% 584
2019
Q4
$667K Hold
13,179
0.01% 629
2019
Q3
$622K Buy
13,179
+940
+8% +$42.9K 0.01% 625
2019
Q2
$576K Hold
12,239
0.01% 623
2019
Q1
$589K Buy
12,239
+869
+8% +$43.5K 0.01% 593
2018
Q4
$507K Buy
11,370
+500
+5% +$26.1K ﹤0.01% 591
2018
Q3
$587K Buy
10,870
+280
+3% +$14.3K ﹤0.01% 609
2018
Q2
$517K Buy
10,590
+350
+3% +$19.8K ﹤0.01% 627
2018
Q1
$642K Buy
10,240
+451
+5% +$30.9K 0.01% 570
2017
Q4
$600K Buy
9,789
+656
+7% +$40.6K ﹤0.01% 583
2017
Q3
$611K Buy
9,133
+133
+1% +$9.4K ﹤0.01% 543
2017
Q2
$701K Hold
9,000
﹤0.01% 502
2017
Q1
$734K Buy
9,000
+900
+11% +$70.8K ﹤0.01% 512
2016
Q4
$583K Sell
8,100
-2,300
-22% -$166K ﹤0.01% 511
2016
Q3
$808K Hold
10,400
﹤0.01% 445
2016
Q2
$811K Buy
10,400
+500
+5% +$39.9K ﹤0.01% 427
2016
Q1
$811K Buy
9,900
+500
+5% +$40.7K 0.01% 416
2015
Q4
$840K Sell
9,400
-2,000
-18% -$170K 0.01% 378
2015
Q3
$876K Buy
11,400
+500
+5% +$41.8K 0.01% 383
2015
Q2
$912K Hold
10,900
0.01% 410
2015
Q1
$984K Buy
10,900
+900
+9% +$77.5K 0.01% 332
2014
Q4
$807K Buy
10,000
+1,400
+16% +$111K 0.01% 346
2014
Q3
$644K Sell
8,600
-600
-7% -$43.7K ﹤0.01% 367
2014
Q2
$631K Hold
9,200
﹤0.01% 360
2014
Q1
$644K Hold
9,200
0.01% 351
2013
Q4
$615K Sell
9,200
-1,100
-11% -$67.2K 0.01% 345
2013
Q3
$537K Hold
10,300
﹤0.01% 364
2013
Q2
$486K Buy
+10,300
New +$470K ﹤0.01% 423

Other funds holding CAH

Daiwa Securities Group's CAH Position: Q2 2026 in Review

Daiwa Securities Group increased its Cardinal Health (CAH) stake by 7.3% in Q2 2026, buying an estimated $1.24M and bringing the position to 87,742 shares worth $20.8M. The position accounts for 0.04% of the portfolio, ranked #247.

Daiwa Securities Group first reported a position in CAH in Q2 2013 and has held it in 53 quarters since. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Daiwa Securities Group held 87,742 shares of Cardinal Health worth $20.8M as of Q2 2026.
  • Daiwa Securities Group bought 5,971 Cardinal Health shares in Q2 2026, an estimated $1.24M.
  • Cardinal Health made up 0.04% of Daiwa Securities Group's portfolio in Q2 2026, its #247 holding.
  • Daiwa Securities Group first reported a position in Cardinal Health in Q2 2013 and has held it in 53 quarters since.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.